Endometriosis

Histology slides
#Endometriosis #Women's health

Oriva appoints Arbat as CEO, advances endometriosis asset 

Women’s health company Oriva Therapeutics has appointed Dr Agnès Arbat as Chief Executive Officer.  Arbat joins with more than 25 years of experience in the pharmaceutical industry, which Oriva says demonstrate a strong track record across clinical development, medical affairs and commercial strategy in women’s health.  Arbat… Read More

#News

Histology slides
#Cyclana Bio #Endometriosis #NHS

Cyclana Bio gets green light to launch endometriosis trial 

Cyclana Bio has been granted Health Research Authority (HRA) and Research Ethics Committee (REC) approval by the NHS to launch a study into endometriosis.  The biotechnology company will now go ahead with its 500-patient clinical observational study, being called PEMP (Predicting Endometriosis Mechanisms and Populations), to improve understanding of the disease… Read More

#News #Regulatory

Endometriosis
#Artificial intelligence (AI) #Automation / robotics #Endometriosis #Women's health

Can AI shrink the drug development timelines for endometriosis?

DDW Deputy Editor Diana Turner speaks to the team behind an ambitious project to identify a novel drug target for endometriosis by the end of the year. The Advanced Research & Invention Agency (ARIA), through its AI Scientist programme, has awarded a £500,000 grant to fund a collaboration between San… Read More

#Exclusive Content

#CureLab Oncology #DNA #endogene.bio #Endometriosis #Genetics #Junevity #MHRA #Ocular diseases #Oncology #Regulatory #UK government #University of California San Francisco #Women's health

DDW Highlights: 20 January 2026

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW’s Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news. Last week, new research in women’s health uncovered significant findings related to endometriosis and… Read More

#Podcasts

#CureLab Oncology #DNA #endogene.bio #Endometriosis #Genetics #Junevity #MHRA #Ocular diseases #Oncology #Ovarian cancer #Regulatory #UK government #University of California San Francisco #Women's health

This week in Drug Discovery (12 – 16 January) 

News round-up for 12 – 16 January by Bruno Quinney, Content Team at DDW.  This week in DDW, new research in women’s health has uncovered significant findings related to endometriosis and ovarian cancer. Elsewhere, can ageing be reversed?  The top stories:    Discovery reveals endometriosis is not… Read More

#News

Endometrial biopsy
#endogene.bio #Endometriosis #Women's health

Discovery reveals endometriosis is not one disorder but many

New research from Paris-based biotech endogene.bio suggests endometriosis is molecularly heterogeneous across patients, lesion sites, and cell types.  This molecular heterogeneity has important implications for how endometriosis treatments are studied and developed.   Treating the disease as a single entity may help explain why many clinical… Read More

#Editor's Choice #Editor's Pick #News

Biomarkers concept
#Biomarkers #Drug discovery #Endometriosis #Genetics / genomics #Neurodegenerative disorders #Neuroscience #Women's health

New podcast: Innovative uses for biomarkers in drug discovery

This is the latest episode of the free DDW narrated podcast, titled “Innovative uses for biomarkers in drug discovery”, which covers two articles written for DDW Volume 24 – Issue 4, Fall 2023. They are called: “How biomarkers can help discover new treatments for women’s health” and… Read More

#News

#Endometriosis #Interview #Women's health

The drug discovery challenges facing endometriosis

DDW Editor Reece Armstrong speaks to Dr Piraye Yurttas Beim about the unmet need for patients with endometriosis and how research could lead to new treatments for ovarian health. RA: What are the current unmet needs for women with endometriosis? PB: Endometriosis is an inflammatory pain condition estimated to impact more… Read More

#Exclusive Content

Endometriosis
#Endometriosis #GLP-1 #Weight loss

Mounjaro’s role in managing endometriosis

Endometriosis is a chronic and often debilitating condition affecting one in 10 women in the UK. Weight management and metabolic health play an essential role in symptom control. The weight loss drug Mounjaro (tirzepatide) and its effects on appetite regulation, insulin sensitivity, and weight loss, could be an unexpected tool… Read More

#News

#Biomarkers #Endometriosis #Genetics / genomics #Women's health

How biomarkers can help discover new treatments for women’s health

Listen to this article on the DDW Podcast: DDW Editor Reece Armstrong speaks to Dr Steve Gardner, Co-Founder and CEO of PrecisionLife about work the company is doing to improve our understanding of endometriosis.  RA: You’ve recently announced a collaboration with the University of Oxford to access genotype data on women… Read More

#Exclusive Content

Endometriosis
#Endometriosis #Genetics / genomics #Personalised medicine #PrecisionLife #University of Oxford #Women's health

Endometriosis partners to discover personalised treatments

PrecisionLife and the University of Oxford have signed a data access agreement to license the Oxford Endometriosis Gene (OXEGENE) dataset to develop new personalised treatments for endometriosis patients. Endometriosis affects 10% of women globally, but on average it takes over seven years for patients to receive… Read More

#News

#Chronic pain #Endometriosis #Epidemiology

Researchers reveal potential endometriosis drug target 

New research conducted by the University of Oxford, Baylor College of Medicine, the University of Wisconsin-Madison and Bayer AG, offers new insight into how to treat endometriosis, a painful, chronic condition in which tissue from the uterus inappropriately grows outside the uterus. Current treatments are limited and include surgery and… Read More

#News